Publications

Featured publications

Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects

September 9, 2021

Maas-Bauer K, Lohmeyer JK, Hirai T, Ramos TL, Fazal FM, Litzenburger UM, Yost KE, Ribado JV, Kambham N, Wenokur AS, Lin PY, Alvarez M, Mavers M, Baker J, Bhatt AS, Chang HY, Simonetta F, Negrin RS. Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects. Blood. 2021 Sep 9;138(10):858-870. doi: 10.1182/blood.2021010887. PMID: 34036317; PMCID: PMC8432044.

Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD

June 8, 2021

Hirai T, Lin PY, Simonetta F, Maas-Bauer K, Turkoz M, Mavers M, Baker J, Negrin RS. Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD. Blood Adv. 2021 Jun 8;5(11):2528-2538. doi: 10.1182/bloodadvances.2020003272. PMID: 34100904; PMCID: PMC8238485.

Activation of the DR3-TL1A axis in Donor Mice Leads to Regulatory T cell Expansion and Activation with Reduction in Graft-Versus-Host Disease

July 17, 2019

Mavers M, Simonetta F, Nishikii H, Ribado JV, Maas-Bauer K, Alvarez M, Hirai T, Turkoz M, Baker J, Negrin RS. Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease. Front Immunol. 2019 Jul 17;10:1624. doi: 10.3389/fimmu.2019.01624. PMID: 31379829; PMCID: PMC6652149.

Invariant natural killer T cells as suppressors of graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

July 31, 2017

Mavers M, Maas-Bauer K, Negrin RS. Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol. 2017 Jul 31;8:900. doi: 10.3389/fimmu.2017.00900. PMID: 28824628; PMCID: PMC5534641.

Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis

January 1, 2012

Mavers M, Cuda CM, Misharin AV, Gierut AK, Agrawal H, Weber E, Novack DV, Haines GK 3rd, Balomenos D, Perlman H. Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis. Arthritis Rheum. 2012 Jan;64(1):141-52. doi: 10.1002/art.33311. PMID: 21898359; PMCID: PMC3253189.

The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages

March 1, 2009

Scatizzi JC, Mavers M, Hutcheson J, Young B, Shi B, Pope RM, Ruderman EM, Samways DS, Corbett JA, Egan TM, Perlman H. The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages. Eur J Immunol. 2009 Mar;39(3):820-5. doi: 10.1002/eji.200838683. PMID: 19189309; PMCID: PMC2734089.

Recent publications

• Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task Force
  June 1, 2024
  Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task ForceSharma, A., Czechowicz, A., Mavers, M., Chao, N., DiPersio, J., Reddy, P., Perales, M. A. & Smith, M., Jun 2024, In: Transplantation and Cellular Therapy. 30, 6, p. 559-564 6 p.Research output: Contribution to journal › Article › peer-review
• Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation
  January 1, 2024
  Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantationPfeiffer, T., Lockowitz, C. R., Shenoy, S., Mavers, M., Hayashi, R., Bednarski, J. & Green, A., 2024, (Accepted/In press) In: Bone Marrow Transplantation.Research output: Contribution to journal › Letter › peer-review
• Inhibiting post-translational methylation to prevent GVHD
  November 1, 2023
  Inhibiting post-translational methylation to prevent GVHDMavers, M., Nov 1 2023, In: Molecular Therapy. 31, 11, p. 3115-3116 2 p.Research output: Contribution to journal › Comment/debate
• Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations
  January 1, 2023
  Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutationsBorna, Š., Lee, E., Nideffer, J., Ramachandran, A., Wang, B., Baker, J., Mavers, M., Lakshmanan, U., Narula, M., Garrett, A. K. H., Schulze, J., Olek, S., Marois, L., Gernez, Y., Bhatia, M., Chong, H. J., Walter, J., Kitcharoensakkul, M., Lang, A. & Cooper, M. A. & 4 others, Bertaina, A., Roncarolo, M. G., Meffre, E. & Bacchetta, R., 2023, In: Science translational medicine. 15, 727, eadg6822.Research output: Contribution to journal › Article › peer-review
• Invariant natural killer T-cell subsets have diverse graft-versus-host-disease–preventing and antitumor effects
  September 9, 2021
  Invariant natural killer T-cell subsets have diverse graft-versus-host-disease–preventing and antitumor effectsMaas-Bauer, K., Lohmeyer, J. K., Hirai, T., Ramos, T. L., Fazal, F. M., Litzenburger, U. M., Yost, K. E., Ribado, J. V., Kambham, N., Wenokur, A. S., Lin, P. Y., Alvarez, M., Mavers, M., Baker, J., Bhatt, A. S., Chang, H. Y., Simonetta, F. & Negrin, R. S., Sep 9 2021, In: Blood. 138, 10, p. 858-870 13 p.Research output: Contribution to journal › Article › peer-review
• Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD
  June 8, 2021
  Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHDHirai, T., Lin, P. Y., Simonetta, F., Maas-Bauer, K., Turkoz, M., Mavers, M., Baker, J. & Negrin, R. S., Jun 8 2021, In: Blood Advances. 5, 11, p. 2528-2538 11 p.Research output: Contribution to journal › Article › peer-review
• Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance
  April 15, 2021
  Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation toleranceHirai, T., Ramos, T. L., Lin, P. Y., Simonetta, F., Su, L. L., Picton, L. K., Baker, J., Lin, J. X., Li, P., Seo, K., Lohmeyer, J. K., Wagers, S. B., Mavers, M., Leonard, W. J., Blazar, B. R., Garcia, K. C. & Negrin, R. S., Apr 15 2021, In: Journal of Clinical Investigation. 131, 8, e139991.Research output: Contribution to journal › Article › peer-review
• Brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in children and adolescents (<18 y) with early relapse hodgkin lymphoma
  March 1, 2021
  Brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in children and adolescents (
• Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host Disease
  February 1, 2021
  Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseElgarten, C. W., Li, Y., Getz, K. D., Hemmer, M., Huang, Y. S. V., Hall, M., Wang, T., Kitko, C. L., Jagasia, M. H., Nishihori, T., Murthy, H. S., Hashem, H., Cairo, M. S., Sharma, A., Hashmi, S. K., Askar, M., Beitinjaneh, A., Kelly, M. S., Auletta, J. J. & Badawy, S. M. & 6 others, Mavers, M., Aplenc, R., MacMillan, M. L., Spellman, S. R., Arora, M. & Fisher, B. T., Feb 2021, In: […]
• Activation of the DR3-TL1A axis in donor mice leads to regulatory T cell expansion and activation with reduction in graft-versus-host disease
  January 1, 2019
  Activation of the DR3-TL1A axis in donor mice leads to regulatory T cell expansion and activation with reduction in graft-versus-host diseaseMavers, M., Simonetta, F., Nishikii, H., Ribado, J. V., Maas-Bauer, K., Alvarez, M., Hirai, T., Turkoz, M., Baker, J. & Negrin, R. S., 2019, In: Frontiers in immunology. 10, JULY, 1624.Research output: Contribution to journal › Article › peer-review